While KKR is primarily a private equity giant, it has exposure to health companies in Europe, notably the major French health group Elsan (AFR). So, while it may take time for HMD to get exposure to other companies and brands, it is definitely a piece of positive news. The downside, perhaps, is that a longer and meatier deal with RHC could get delayed.
While KKR is primarily a private equity giant, it has exposure...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
